The epidemiology of human papillomavirus infections

Journal of Clinical Virology

Volumn 32, Issue SUPPL., 2005, Pages 16-24

  Baseman, Janet G ^a   Koutsky, Laura A ^a  

^a HPV Research Group   (United States)

Author keywords

Cervical cancer; Epidemiology; Human papillomavirus (HPV); Natural history; Sexually transmitted infection (STI)

Indexed keywords

ORAL CONTRACEPTIVE AGENT; VIRUS VACCINE;

CONDOM; DISEASE COURSE; FOLLOW UP; HEALTH CARE COST; HUMAN; IMMUNE RESPONSE; IMMUNITY; MORBIDITY; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW; RISK FACTOR; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASE; SMOKING; UTERINE CERVIX CANCER; VIRUS INFECTION; VIRUS PARTICLE; WART VIRUS;

EID: 14744293594     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcv.2004.12.008     Document Type: Review

References (83)

1. V. af Geijersstam, Z. Wang, I. Lewensohn-Fuchs, C. Eklund, J.T. Schiller, and M. Forsgren Trends in seroprevalence of human papillomavirus type 16 among pregnant women in Stockholm, Sweden, during 1969-1989 Int J Cancer 76 3 1998 341 344
2. B. Bachtiary, G. Obermair, B. Dreier, P. Birner, G. Breitenecker, and T.H. Knocke Impact of multiple HPV infection on response to treatment and survival in patients receiving radical radiotherapy for cervical cancer Int J Cancer 102 3 2002 237 243
3. H.M. Bauer, A. Hildesheim, M.H. Schiffman, A.G. Glass, B.B. Rush, and D.R. Scott Determinants of genital human papillomavirus infection in low-risk women in Portland, Oregon Sex Transm Dis 20 5 1993 274 278
4. T.M. Becker, K.M. Stone, and E.R. Alexander Genital human papillomavirus infection. A growing concern Obstet Gynecol Clin North Am 14 2 1987 389 396
5. J. Berumen, R.M. Ordonez, E. Lazcano, J. Salmeron, S.C. Galvan, and R.A. Estrada Asian-American variants of human papillomavirus 16 and risk for cervical cancer: a case-control study J Natl Cancer Inst 93 17 2001 1325 1330
6. F.X. Bosch, and S. de Sanjose Chapter 1: human papillomavirus and cervical cancer - burden and assessment of causality J Natl Cancer Inst Monogr 31 2003 3 13
7. D.R. Brown, J.T. Bryan, J.M. Schroeder, T.S. Robinson, K.H. Fife, and C.M. Wheeler Neutralization of human papillomavirus type 11 (HPV-11) by serum from women vaccinated with yeast-derived HPV-11 L1 virus-like particles: correlation with competitive radioimmunoassay titer J Infect Dis 184 9 2001 1183 1186
8. R.D. Burk, G.Y. Ho, L. Beardsley, M. Lempa, M. Peters, and R. Bierman Sexual behavior and partner characteristics are the predominant risk factors for genital human papillomavirus infection in young women J Infect Dis 174 4 1996 679 689
9. J.J. Carter, L.A. Koutsky, J.P. Hughes, S.K. Lee, J. Kuypers, and N. Kiviat Comparison of human papillomavirus types 16, 18 and 6 capsid antibody responses following incident infection J Infect Dis 181 6 2000 1911 1919
10. J.J. Carter, L.A. Koutsky, G.C. Wipf, N.D. Christensen, S.K. Lee, and J. Kuypers The natural history of human papillomavirus type 16 capsid antibodies among a cohort of university women J. Infect. Dis. 174 5 1996 927 936
11. T.Y. Chuang, H.O. Perry, L.T. Kurland, and D.M. Ilstrup Condyloma acuminatum in Rochester, MI, 1950-1978. I. Epidemiology and clinical features Arch Dermatol 120 4 1984 469 475
12. M.A. Clark, A. Hartley, and J.I. Geh Cancer of the anal canal Lancet Oncol 5 3 2004 149 157
13. S. Cohen Beyond slogans: lessons from Uganda's experience with ABC and HIV/AIDS The Guttmacher report on public policy. Series beyond slogans: lessons from Uganda's experience with ABC and HIV/AIDS 2003 1-3
14. K.S. Cuschieri, H.A. Cubie, M.W. Whitley, A.L. Seagar, M.J. Arends, and C. Moore Multiple high-risk HPV infections are common in cervical neoplasia and young women in a cervical screening population J Clin Pathol 57 1 2004 68 72
15. K.S. Cuschieri, M.J. Whitley, and H.A. Cubie Human papillomavirus type specific DNA and RNA persistence - implications for cervical disease progression and monitoring J Med Virol 73 1 2004 65 70
16. J.R. Daling, M.M. Madeleine, S.M. Schwartz, K.A. Shera, J.J. Carter, and B. McKnight A population-based study of squamous cell vaginal cancer: HPV and cofactors Gynecol Oncol 84 2 2002 263 270
17. M. Davidson, P.G. Schnitzer, L.R. Bulkow, A.J. Parkinson, M.L. Schloss, and M.A. Fitzgerald The prevalence of cervical infection with human papillomaviruses and cervical dysplasia in Alaska native women J Infect Dis 169 4 1994 792 800
18. J.M. Deacon, C.D. Evans, R. Yule, M. Desai, W. Binns, and C. Taylor Sexual behaviour and smoking as determinants of cervical HPV infection and of CIN3 among those infected: a case-control study nested within the Manchester cohort Br J Cancer 83 11 2000 1565 1572
19. M.H. Einstein, and G.L. Goldberg Human papillomavirus and cervical neoplasia Cancer Invest 20 7-8 2002 1080 1085
20. R.T. Emeny, C.M. Wheeler, K.U. Jansen, W.C. Hunt, T.M. Fu, and J.F. Smith Priming of human papillomavirus type 11-specific humoral and cellular immune responses in college-aged women with a virus-like particle vaccine J Virol 76 15 2002 7832 7842
21. M. Evander, K. Edlund, A. Gustafsson, M. Jonsson, R. Karlsson, and E. Rylander Human papillomavirus infection is transient in young women: a population-based cohort study J Infect Dis 171 4 1995 1026 1030
22. T.G. Evans, W. Bonnez, R.C. Rose, S. Koenig, L. Demeter, and J.A. Suzich A phase 1 study of a recombinant viruslike particle vaccine against human papillomavirus type 11 in healthy adult volunteers J Infect Dis 183 10 2001 1485 1493
23. S. Franceschi, X. Castellsague, L. Dal Maso, J.S. Smith, M. Plummer, and C. Ngelangel Prevalence and determinants of human papillomavirus genital infection in men Br J Cancer 86 5 2002 705 711
24. E.L. Franco, L.L. Villa, J.P. Sobrinho, J.M. Prado, M.C. Rousseau, and M. Desy Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high-risk area for cervical cancer J Infect Dis 180 5 1999 1415 1423
25. M.L. Gillison, and D.R. Lowy A causal role for human papillomavirus in head and neck cancer Lancet 363 9420 2004 1488 1489
26. A.R. Giuliano, R. Harris, R.L. Sedjo, S. Baldwin, D. Roe, and M.R. Papenfuss Incidence, prevalence, and clearance of type-specific human papillomavirus infections: The Young Women's Health Study J Infect Dis 186 4 2002 462 469
27. S.J. Goldie, M. Kohli, D. Grima, M.C. Weinstein, T.C. Wright, and F.X. Bosch Projected clinical benefits and cost-effectiveness of a human papillomavirus 16/18 vaccine J Natl Cancer Inst 96 8 2004 604 615
28. C.E. Greer, C.M. Wheeler, M.B. Ladner, K. Beutner, M.Y. Coyne, and H. Liang Human papillomavirus (HPV) type distribution and serological response to HPV type 6 virus-like particles in patients with genital warts J Clin Microbiol 33 8 1995 2058 2063
29. T.G. Harris, S.L. Kulasingam, N.B. Kiviat, C. Mao, S.N. Agoff, and Q. Feng Cigarette smoking, oncogenic human papillomavirus, Ki-67 antigen, and cervical intraepithelial neoplasia Am J Epidemiol 159 9 2004 834 842
30. C.D. Harro, Y.Y. Pang, R.B. Roden, A. Hildesheim, Z. Wang, and M.J. Reynolds Safety and immunogenicity trial in adult volunteers of a human papillomavirus 16 L1 virus-like particle vaccine J Natl Cancer Inst 93 4 2001 284 292
31. R. Herrero, A. Hildesheim, C. Bratti, M.E. Sherman, M. Hutchinson, and J. Morales Population-based study of human papillomavirus infection and cervical neoplasia in rural Costa Rica J Natl Cancer Inst 92 6 2000 464 474
32. A. Hildesheim, R. Herrero, P.E. Castle, S. Wacholder, M.C. Bratti, and M.E. Sherman HPV co-factors related to the development of cervical cancer: results from a population-based study in Costa Rica Br J Cancer 84 9 2001 1219 1226
33. A. Hildesheim, M.H. Schiffman, P.E. Gravitt, A.G. Glass, C.E. Greer, and T. Zhang Persistence of type-specific human papillomavirus infection among cytologically normal women J Infect Dis 169 2 1994 235 240
34. S.A. Hinchliffe, D. van Velzen, H. Korporaal, P.L. Kok, and M.E. Boon Transience of cervical HPV infection in sexually active, young women with normal cervicovaginal cytology Br J Cancer 72 4 1995 943 945
35. M. Hippelainen, S. Syrjanen, H. Koskela, J. Pulkkinen, S. Saarikoski, and K. Syrjanen Prevalence and risk factors of genital human papillomavirus (HPV) infections in healthy males: a study on Finnish conscripts Sex Transm Dis 20 6 1993 321 328
36. G.Y. Ho, R. Bierman, L. Beardsley, C.J. Chang, and R.D. Burk Natural history of cervicovaginal papillomavirus infection in young women N Engl J Med 338 7 1998 423 428
37. G.Y. Ho, Y.Y. Studentsov, R. Bierman, and R.D. Burk Natural history of human papillomavirus type 16 virus-like particle antibodies in young women Cancer Epidemiol. Biomarkers Prev. 13 1 2004 110 116
38. IARC (International Agency for Research on Cancer). Monograph on the evaluation of carcinogenic risks to humans, vol 64. Human papillomaviruses. Lyon: IARC, 1995.
39. S. Jeon, and P.F. Lambert Integration of human papillomavirus type 16 DNA into the human genome leads to increased stability of E6 and E7 mRNAs: implications for cervical carcinogenesis Proc Natl Acad Sci USA 92 5 1995 1654 1658
40. S.B. Jones Cancer in the developing world: a call to action BMJ 319 7208 1999 505 508
41. R. Karlsson, M. Jonsson, K. Edlund, M. Evander, A. Gustavsson, and E. Boden Lifetime number of partners as the only independent risk factor for human papillomavirus infection: a population-based study Sex Transm Dis 22 2 1995 119 127
42. L.J. Kinlen, and A.I. Spriggs Women with positive cervical smears but without surgical intervention. A follow-up study Lancet 2 8087 1978 463 465
43. R. Kirnbauer, F. Booy, N. Cheng, D.R. Lowy, and J.T. Schiller Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic Proc Natl Acad Sci USA 89 24 1992 12180 12184
44. L.A. Koutsky, K.A. Ault, C.M. Wheeler, D.R. Brown, E. Barr, and F.B. Alvarez A controlled trial of a human papillomavirus type 16 vaccine N Engl J Med 347 21 2002 1645 1651
45. L.A. Koutsky, K.K. Holmes, C.W. Critchlow, C.E. Stevens, J. Paavonen, and A.M. Beckmann A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection N Engl J Med 327 18 1992 1272 1278
46. S.L. Kulasingam, J.P. Hughes, N.B. Kiviat, C. Mao, N.S. Weiss, and J.M. Kuypers Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral JAMA 288 14 2002 1749 1757
47. S.L. Kulasingam, and E.R. Myers Potential health and economic impact of adding a human papillomavirus vaccine to screening programs JAMA 290 6 2003 781 789
48. P. Laukkanen, P. Koskela, E. Pukkala, J. Dillner, E. Laara, and P. Knekt Time trends in incidence and prevalence of human papillomavirus type 6, 11 and 16 infections in Finland J Gen Virol 84 Pt 8 2003 2105 2109
49. C. Ley, H.M. Bauer, A. Reingold, M.H. Schiffman, J.C. Chambers, and C.J. Tashiro Determinants of genital human papillomavirus infection in young women J Natl Cancer Inst 83 14 1991 997 1003
50. K.L. Liaw, A.G. Glass, M.M. Manos, C.E. Greer, D.R. Scott, and M. Sherman Detection of human papillomavirus DNA in cytologically normal women and subsequent cervical squamous intraepithelial lesions J Natl Cancer Inst 91 11 1999 954 960
51. K.L. Liaw, A. Hildesheim, R.D. Burk, P. Gravitt, S. Wacholder, and M.M. Manos A prospective study of human papillomavirus (HPV) type 16 DNA detection by polymerase chain reaction and its association with acquisition and persistence of other HPV types J Infect Dis 183 1 2001 8 15
52. L.E. Manhart, and L.A. Koutsky Do condoms prevent genital HPV infection, external genital warts, or cervical neoplasia? A meta-analysis Sex Transm Dis 29 11 2002 725 735
53. V. Moreno, F.X. Bosch, N. Munoz, C.J. Meijer, K.V. Shah, and J.M. Walboomers Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection: the IARC multicentric case-control study Lancet 359 9312 2002 1085 1092
54. N. Munoz, F.X. Bosch, S. de Sanjose, R. Herrero, X. Castellsague, and K.V. Shah Epidemiologic classification of human papillomavirus types associated with cervical cancer N Engl J Med 348 6 2003 518 527
55. N. Munoz, S. Franceschi, C. Bosetti, V. Moreno, R. Herrero, and J.S. Smith Role of parity and human papillomavirus in cervical cancer: the IARC multicentric case-control study Lancet 359 9312 2002 1093 1101
56. B.P. Negrini, M.H. Schiffman, R.J. Kurman, W. Barnes, L. Lannom, and K. Malley Oral contraceptive use, human papillomavirus infection, and risk of early cytological abnormalities of the cervix Cancer Res 50 15 1990 4670 4675
57. S. Pecorelli, G. Favalli, L. Zigliani, and F. Odicino Cancer in women Int J Gynaecol Obstet 82 3 2003 369 379
58. O. Petersen Spontaneous course of cervical precancerous conditions Am J Obstet Gynecol 72 5 1956 1063 1071
59. H. Richardson, G. Kelsall, P. Tellier, H. Voyer, M. Abrahamowicz, and A. Ferenczy The natural history of type-specific human papillomavirus infections in female university students Cancer Epidemiol Biomarkers Prev 12 6 2003 485 490
60. L. Ries, M. Eisner, C. Kosary, B. Hankey, B. Miller, and L. Clegg SEER cancer statistics review, 1975-2001 2004 National Cancer Institute Bethesda, MD http://seer.cancer.gov/csr/1975_2001
61. T. Rohan, V. Mann, J. McLaughlin, D.G. Harnish, H. Yu, and D. Smith PCR-detected genital papillomavirus infection: prevalence and association with risk factors for cervical cancer Int J Cancer 49 6 1991 856 860
62. M.C. Rousseau, J.S. Pereira, J.C. Prado, L.L. Villa, T.E. Rohan, and E.L. Franco Cervical coinfection with human papillomavirus (HPV) types as a predictor of acquisition and persistence of HPV infection J Infect Dis 184 12 2001 1508 1517
63. M.A. Rubin, B. Kleter, M. Zhou, G. Ayala, A.L. Cubilla, and W.G. Quint Detection and typing of human papillomavirus DNA in penile carcinoma: evidence for multiple independent pathways of penile carcinogenesis Am J Pathol 159 4 2001 1211 1218
64. M.H. Schiffman Recent progress in defining the epidemiology of human papillomavirus infection and cervical neoplasia J Natl Cancer Inst 84 6 1992 394 398
65. J.S. Smith, N. Munoz, R. Herrero, J. Eluf-Neto, C. Ngelangel, and S. Franceschi Evidence for Chlamydia trachomatis as a human papillomavirus cofactor in the etiology of invasive cervical cancer in Brazil and the Philippines J Infect Dis 185 3 2002 324 331
66. Steenbergen R, de Wilde J, Wilting SM, Brink AATP, Snijders PJF, Meijer CJLM. HPV-mediated transformation of the anogenital tract. J Clin Virol, this volume.
67. Stern PL,, 2005. Immune control of human papillomavirus (HPV) associated anogenital disease and potential for vaccination. J Clin Virol, this volume.
68. K.M. Stone, K.L. Karem, M.R. Sternberg, G.M. McQuillan, A.D. Poon, and E.R. Unger Seroprevalence of human papillomavirus type 16 infection in the United States J Infect Dis 186 10 2002 1396 1402
69. E.I. Svare, S.K. Kjaer, A.M. Worm, A. Osterlind, C.J. Meijer, and A.J. van den Brule Risk factors for genital HPV DNA in men resemble those found in women: a study of male attendees at a Danish STD clinic Sex Transm Infect 78 3 2002 215 218
70. T.A. Tarkowski, E.H. Koumans, M. Sawyer, A. Pierce, C.M. Black, and J.R. Papp Epidemiology of human papillomavirus infection and abnormal cytologic test results in an urban adolescent population J Infect Dis 189 1 2004 46 50
71. M.L. Tornesello, M.L. Duraturo, I. Salatiello, L. Buonaguro, S. Losito, and G. Botti Analysis of human papillomavirus type-16 variants in Italian women with cervical intraepithelial neoplasia and cervical cancer J Med Virol 74 1 2004 117 126
72. C.L. Trimble, A. Hildesheim, L.A. Brinton, K.V. Shah, and R.J. Kurman Heterogeneous etiology of squamous carcinoma of the vulva Obstet Gynecol 87 1 1996 59 64
73. Y. van der Graaf, A. Molijn, H. Doornewaard, W. Quint, L.J. van Doorn, and J. van den Tweel Human papillomavirus and the long-term risk of cervical neoplasia Am. J. Epidemiol. 156 2 2002 158 164
74. S.D. Vernon, W.C. Reeves, K.A. Clancy, M. Laga, M. St Louis, and H.E. Gary Jr. A longitudinal study of human papillomavirus DNA detection in human immunodeficiency virus type 1-seropositive and -seronegative women J Infect Dis 169 5 1994 1108 1112
75. S.S. Wang, M. Schiffman, T.S. Shields, R. Herrero, A. Hildesheim, and M.C. Bratti Seroprevalence of human papillomavirus-16, -18, -31, and -45 in a population-based cohort of 10,000 women in Costa Rica Br J Cancer 89 7 2003 1248 1254
76. B.A. Weaver, Q. Feng, K.K. Holmes, N. Kiviat, S.K. Lee, and C. Meyer Evaluation of genital sites and sampling techniques for detection of human papillomavirus DNA in men J Infect Dis 189 4 2004 677 685
77. C.M. Wheeler, C.A. Parmenter, W.C. Hunt, T.M. Becker, C.E. Greer, and A. Hildesheim Determinants of genital human papillomavirus infection among cytologically normal women attending the University of New Mexico student health center Sex Transm Dis 20 5 1993 286 289
78. R.L. Winer, S.K. Lee, J.P. Hughes, D.E. Adam, N.B. Kiviat, and L.A. Koutsky Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students Am J Epidemiol 157 3 2003 218 226
79. C.B. Woodman, S. Collins, H. Winter, A. Bailey, J. Ellis, and P. Prior Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study Lancet 357 9271 2001 1831 1836
80. L.F. Xi, G.W. Demers, L.A. Koutsky, N.B. Kiviat, J. Kuypers, and D.H. Watts Analysis of human papillomavirus type 16 variants indicates establishment of persistent infection J Infect Dis 172 3 1995 747 755
81. L.F. Xi, L.A. Koutsky, D.A. Galloway, J. Kuypers, J.P. Hughes, and C.M. Wheeler Genomic variation of human papillomavirus type 16 and risk for high-grade cervical intraepithelial neoplasia J Natl Cancer Inst 89 11 1997 796 802
82. H. zur Hausen Roots and perspectives of contemporary papillomavirus research J. Cancer Res. Clin. Oncol. 122 1 1996 3 13
83. J. Zhou, X.Y. Sun, D.J. Stenzel, and I.H. Frazer Expression of vaccinia recombinant HPV 16 L1 and L2 ORF proteins in epithelial cells is sufficient for assembly of HPV virion-like particles Virology 185 1 1991 251 257